BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

912 related articles for article (PubMed ID: 26599135)

  • 1. Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade.
    Ebdrup BH; Raghava JM; Nielsen MØ; Rostrup E; Glenthøj B
    J Psychiatry Neurosci; 2016 Mar; 41(2):133-41. PubMed ID: 26599135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal white matter microstructure in drug-naive first episode schizophrenia patients before and after eight weeks of antipsychotic treatment.
    Zeng B; Ardekani BA; Tang Y; Zhang T; Zhao S; Cui H; Fan X; Zhuo K; Li C; Xu Y; Goff DC; Wang J
    Schizophr Res; 2016 Apr; 172(1-3):1-8. PubMed ID: 26852402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.
    Nørbak-Emig H; Ebdrup BH; Fagerlund B; Svarer C; Rasmussen H; Friberg L; Allerup PN; Rostrup E; Pinborg LH; Glenthøj BY
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26819282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Blocking D2/D3 Receptors on Mismatch Negativity and P3a Amplitude of Initially Antipsychotic Naïve, First Episode Schizophrenia Patients.
    Düring S; Glenthøj BY; Oranje B
    Int J Neuropsychopharmacol; 2015 Oct; 19(3):pyv109. PubMed ID: 26453696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtle white matter alterations in schizophrenia identified with a new measure of fiber density.
    Stämpfli P; Sommer S; Manoliu A; Burrer A; Schmidt A; Herdener M; Seifritz E; Kaiser S; Kirschner M
    Sci Rep; 2019 Mar; 9(1):4636. PubMed ID: 30874571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline symptom-related white matter tracts predict individualized treatment response to 12-week antipsychotic monotherapies in first-episode schizophrenia.
    Chen Y; Liu S; Zhang B; Zhao G; Zhang Z; Li S; Li H; Yu X; Deng H; Cao H
    Transl Psychiatry; 2024 Jan; 14(1):23. PubMed ID: 38218952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal D(2/3) Binding Potential Values in Drug-Naïve First-Episode Schizophrenia Patients Correlate With Treatment Outcome.
    Wulff S; Pinborg LH; Svarer C; Jensen LT; Nielsen MØ; Allerup P; Bak N; Rasmussen H; Frandsen E; Rostrup E; Glenthøj BY
    Schizophr Bull; 2015 Sep; 41(5):1143-52. PubMed ID: 25698711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dopamine D2/D3 blockade on human sensory and sensorimotor gating in initially antipsychotic-naive, first-episode schizophrenia patients.
    Düring S; Glenthøj BY; Andersen GS; Oranje B
    Neuropsychopharmacology; 2014 Dec; 39(13):3000-8. PubMed ID: 24954063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of white matter characteristics with tract-based spatial statistics according to diffusion tensor imaging in early Parkinson's disease.
    Li XR; Ren YD; Cao B; Huang XL
    Neurosci Lett; 2018 May; 675():127-132. PubMed ID: 29199095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrastriatal dopamine D
    Nørbak-Emig H; Pinborg LH; Raghava JM; Svarer C; Baaré WFC; Allerup P; Friberg L; Rostrup E; Glenthøj B; Ebdrup BH
    World J Biol Psychiatry; 2017 Oct; 18(7):539-549. PubMed ID: 27782768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients.
    Bressan RA; Erlandsson K; Spencer EP; Ell PJ; Pilowsky LS
    Psychopharmacology (Berl); 2004 Sep; 175(3):367-73. PubMed ID: 14997280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment.
    Wang Q; Cheung C; Deng W; Li M; Huang C; Ma X; Wang Y; Jiang L; Sham PC; Collier DA; Gong Q; Chua SE; McAlonan GM; Li T
    Psychol Med; 2013 Nov; 43(11):2301-9. PubMed ID: 23442742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gray and white matter changes and their relation to illness trajectory in first episode psychosis.
    Keymer-Gausset A; Alonso-Solís A; Corripio I; Sauras-Quetcuti RB; Pomarol-Clotet E; Canales-Rodriguez EJ; Grasa-Bello E; Álvarez E; Portella MJ
    Eur Neuropsychopharmacol; 2018 Mar; 28(3):392-400. PubMed ID: 29338891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of clozapine on white matter integrity in patients with schizophrenia: a diffusion tensor imaging study.
    Ozcelik-Eroglu E; Ertugrul A; Oguz KK; Has AC; Karahan S; Yazici MK
    Psychiatry Res; 2014 Sep; 223(3):226-35. PubMed ID: 25012780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State-dependent microstructural white matter changes in drug-naïve patients with first-episode psychosis.
    Serpa MH; Doshi J; Erus G; Chaim-Avancini TM; Cavallet M; van de Bilt MT; Sallet PC; Gattaz WF; Davatzikos C; Busatto GF; Zanetti MV
    Psychol Med; 2017 Nov; 47(15):2613-2627. PubMed ID: 28826419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging study.
    Ochi R; Noda Y; Tsuchimoto S; Tarumi R; Honda S; Matsushita K; Tsugawa S; Plitman E; Masuda F; Ogyu K; Wada M; Miyazaki T; Fujii S; Chakravarty MM; Graff-Guerrero A; Uchida H; Mimura M; Nakajima S
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jun; 100():109871. PubMed ID: 31962187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amisulpride a selective dopamine antagonist and atypical antipsychotic: results of a meta-analysis of randomized controlled trials.
    Leucht S
    Int J Neuropsychopharmacol; 2004 Mar; 7 Suppl 1():S15-20. PubMed ID: 14972080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities in brain white matter in adolescents with 22q11.2 deletion syndrome and psychotic symptoms.
    Kikinis Z; Cho KIK; Coman IL; Radoeva PD; Bouix S; Tang Y; Eckbo R; Makris N; Kwon JS; Kubicki M; Antshel KM; Fremont W; Shenton ME; Kates WR
    Brain Imaging Behav; 2017 Oct; 11(5):1353-1364. PubMed ID: 27730479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired empathic abilities and reduced white matter integrity in schizophrenia.
    Fujino J; Takahashi H; Miyata J; Sugihara G; Kubota M; Sasamoto A; Fujiwara H; Aso T; Fukuyama H; Murai T
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():117-23. PubMed ID: 24099786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study.
    la Fougère C; Meisenzahl E; Schmitt G; Stauss J; Frodl T; Tatsch K; Hahn K; Möller HJ; Dresel S
    J Nucl Med; 2005 Jun; 46(6):1028-33. PubMed ID: 15937316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.